reports
Clariant AG: 1 director
A director at Clariant AG bought 5,000 shares at 11.062CHF and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Moody's Ratings upgrades Clariant to investment grade and assigns Baa3...
Moody's Ratings (Moody's) has today assigned a Baa3 long-term issuer rating of Swiss headquartered specialty chemicals company Clariant AG (Clariant or the company). Concurrently, we withdrew its Ba1 corporate family rating (CFR) and Ba1-PD probability of default rating (PDR). Outlook changed to sta...
- Michael B. Schäfer
ODDO BHF Small & MIDCAP MORNING NEWS - 10/29/2024
Temenos, the European leader in core banking solutions with significant market share with Tier 3, 4 and 5 banks, faces structural challenges that impair its growth outlook: 1/ the reticence of major banking groups to renew their core banking system; 2/ fierce competition in the digital segment; and 3/ the slowdown in the launch pace for new neo-banks. Indeed, the group is set to scale back its medium-term targets at its CMD on 12 November. Moreover, the support for the stock offered b...
- Michael B. Schäfer
ODDO BHF S all & MIDCAP MORNING NEWS - 29/10/2024
Temenos, leader européen des solutions Core Banking avec une part de marché significative auprès des banques Tiers 3, 4 et 5, fait face des défis structurels qui réduisent ses perspectives de croissance : 1/ la réticence des grands acteurs bancaires à renouveler leur Core banking system; 2/ la forte compétition sur le segment Digital et 3/ le ralentissement du rythme de lancement de nouvelles néo-banques. Aussi, le groupe devrait abaisser ses objectifs MT lors du CMD du 12 novembre. E...
- Michael B. Schäfer
Clariant : Q3 EBITDA -7% vs css due to a CHF 10m restructuring provisi...
>Organic sales down by 3% y-o-y fuelled by 3% lower volumes - Organic sales down by 3% y-o-y fuelled by 3% lower volumes in Q3 2024 (Q2 2024: 0%) and flat% y-o-y prices (Q2 2024: -3%) as well as 3% forex headwinds pushing sales down by 4% y-o-y to CHF 991m (cons./ODDO BHF CHF 1,010m/CHF 992m). The main drag on volumes was the continuing weakness of the catalysts business, showing a -20% y-o-y volume decline in Q3 (Q2 2024: -18% y-o-y) against a high comparison base. ...
- Michael B. Schäfer
- Sinan Doganli
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 07/30/2024
With regard to our list of recommended stocks, i) we are adding: adidas, Merck KGaA, Santander, Technip FMC, Unilever and Vivendi , ii) we are maintaining ASMi, Atlas Copco, AXA, Deutsche Boerse, GSK, Holcim, Inditex, Lonza, Sodexo, RELX and Rolls-Royce, iii) we are removing: BASF, Nemetschek, Nestlé and TUI AG. - ...
- Michael B. Schäfer
- Sinan Doganli
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 30/07/2024
Au sein de notre liste de valeurs recommandées, i) nous faisons entrer : adidas, Merck KGaA, Santander, Technip FMC, Unilever et Vivendi, ii) nous maintenons ASMi, Atlas Copco, Axa, Deutsche Boerse, GSK, Holicm, Inditex, Lonza, Sodexo, RELX et Rolls-Royce, iii) nous faisons sortir : BASF, Nemetschek, Nestlé, TUI AG. - ...
NK IMERYS SA
ALDEL DELFINGEN INDUSTRY SA
EKI EKINOPS SA
MRN MERSEN SA
EBRO EBRO FOODS SA
COR CORTICEIRA AMORIM SGPS SA
IDR INDRA SISTEMAS S.A. CLASS A
SAE SHOP APOTHEKE EUROPE NV
DUFN DUFRY AG
GEST GESTAMP AUTOMOCION S.A.
THEP THERMADOR HOLDING SA
FPE3 FUCHS PETROLUB SE
ALLFG ALLFUNDS (UK) LTD
- Michael B. Schäfer
Clariant : Q2 EBITDA in line, higher margin guidance also in line. On ...
>Organic sales down 3% solely on pricing (pass-through) - Organic sales down by 3% y-o-y fuelled by flat volumes in Q2 2024 (Q1 24: -1%) and -3% y-o-y in prices (Q1 2024: -5%) mainly via pass-throughs as well as 0% forex pushed sales down 3%y-o-y to CHF 1,056m (cons./ODDO BHF CHF 1,036m/CHF 1,030m). Q2 EBITDA CHF 166m in line with cons. of CHF 164m (ODDO BHF CHF 1 60m) - Q2 EBITDA was CHF 166m, 1% above the consensus forecast for CHF 164m (ODDO BHF ...
- Michael B. Schäfer
Clariant : Cleaned up and growing again
We are initiating coverage of Clariant with an Outperform rating and a target price of CHF 18, harbouring 23% upside to current trading. Clariant has transformed into a consumer-centric (42% of sales) specialty chemicals producer in recent years. Multiple years of restructurings came to an end in 2023 or may have their final cash outflow in 2024. This cleaned-up and streamlined business model forms the basis of a primarily (75%) self-help driven EBITDA recovery to CHF 825m in 20...
Moody's affirms Clariant's Ba1 ratings; positive outlook
Moody's Investors Service, (Moody's) has today affirmed all the ratings of Swiss headquartered specialty chemicals company Clariant AG (Clariant or the company), which comprise the Ba1 long term corporate family rating (CFR), the Ba1- PD probability of default rating (PDR) and the Ba1 rating for the...
Moody's changes Clariant's outlook to positive from stable, affirms Ba...
Moody's Investors Service ("Moody's") has today changed the outlook to positive from stable on all ratings of Clariant AG ("Clariant or the company"). At the same time, Moody's has affirmed the Ba1 corporate family rating (CFR), the Ba1-PD probability of default rating (PDR) and the Ba1 rating for t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.